在细胞癌中尿路miRNA的评估:系统性审查

Giovanni Cochetti1, Liliana Guadagni1, Alessio Paladini1

  • 1Urology Clinic, Department of Medicine and Surgery, Santa Maria della Misericordia Hospital, University of Perugia, 06129 Perugia, Italy.

Cancers
|April 26, 2025
PubMed
概括

这一系统性审查分析了尿路微RNA (miRNAs) 以诊断细胞癌 (RCC). 在RCC患者中,miR-210和let-7家族的高调,手术后水平下降.